Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER SUVEN LIFE SCIENCES PFIZER/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 38.2 -20.5 - View Chart
P/BV x 6.0 5.8 103.3% View Chart
Dividend Yield % 1.7 0.0 -  

Financials

 PFIZER   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    PFIZER
Mar-23
SUVEN LIFE SCIENCES
Mar-23
PFIZER/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs4,66294 4,972.6%   
Low Rs3,40745 7,569.3%   
Sales per share (Unadj.) Rs530.00.6 85,366.4%  
Earnings per share (Unadj.) Rs136.4-5.4 -2,514.6%  
Cash flow per share (Unadj.) Rs159.4-5.1 -3,112.0%  
Dividends per share (Unadj.) Rs70.000-  
Avg Dividend yield %1.70-  
Book value per share (Unadj.) Rs701.017.2 4,073.3%  
Shares outstanding (eoy) m45.75218.07 21.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.6111.8 6.8%   
Avg P/E ratio x29.6-12.8 -231.2%  
P/CF ratio (eoy) x25.3-13.5 -186.8%  
Price / Book Value ratio x5.84.0 142.7%  
Dividend payout %51.30-   
Avg Mkt Cap Rs m184,57615,131 1,219.9%   
No. of employees `000NANA-   
Total wages/salary Rs m3,317186 1,781.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m24,248135 17,909.4%  
Other income Rs m1,01184 1,196.0%   
Total revenues Rs m25,258220 11,487.2%   
Gross profit Rs m8,420-1,196 -703.8%  
Depreciation Rs m1,05565 1,612.6%   
Interest Rs m1355 2,505.6%   
Profit before tax Rs m8,240-1,183 -696.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,0010-   
Profit after tax Rs m6,239-1,183 -527.6%  
Gross profit margin %34.7-883.6 -3.9%  
Effective tax rate %24.30-   
Net profit margin %25.7-873.5 -2.9%  
BALANCE SHEET DATA
Current assets Rs m24,9333,455 721.7%   
Current liabilities Rs m6,5741,050 625.9%   
Net working cap to sales %75.71,776.0 4.3%  
Current ratio x3.83.3 115.3%  
Inventory Days Days933,948 2.4%  
Debtors Days Days2218 1.0%  
Net fixed assets Rs m13,7801,373 1,003.4%   
Share capital Rs m458218 209.8%   
"Free" reserves Rs m31,6163,535 894.3%   
Net worth Rs m32,0733,753 854.6%   
Long term debt Rs m00-   
Total assets Rs m39,0314,828 808.4%  
Interest coverage x62.1-218.8 -28.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60 2,215.4%   
Return on assets %16.3-24.4 -67.0%  
Return on equity %19.5-31.5 -61.7%  
Return on capital %26.1-31.4 -83.2%  
Exports to sales %2.840.4 7.0%   
Imports to sales %0839.8 0.0%   
Exports (fob) Rs m68855 1,256.3%   
Imports (cif) Rs m81,137 0.7%   
Fx inflow Rs m68855 1,256.3%   
Fx outflow Rs m81,137 0.7%   
Net fx Rs m679-1,082 -62.8%   
CASH FLOW
From Operations Rs m3,557-1,031 -344.8%  
From Investments Rs m-361-2,606 13.8%  
From Financial Activity Rs m-3,4583,955 -87.4%  
Net Cashflow Rs m-262317 -82.4%  

Share Holding

Indian Promoters % 0.0 69.6 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 18.2 0.6 3,305.5%  
FIIs % 3.0 0.5 561.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 30.4 118.6%  
Shareholders   112,456 74,003 152.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Pfizer vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Pfizer vs Suven Life Sciences Share Price Performance

Period Pfizer Suven Life Sciences S&P BSE HEALTHCARE
1-Day -4.80% 0.30% 1.18%
1-Month -8.24% -2.06% -0.75%
1-Year 21.78% 114.92% 61.82%
3-Year CAGR -2.07% 14.94% 18.16%
5-Year CAGR 4.95% -16.22% 19.79%

* Compound Annual Growth Rate

Here are more details on the Pfizer share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of Pfizer hold a 63.9% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Pfizer and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, Pfizer paid a dividend of Rs 70.0 per share. This amounted to a Dividend Payout ratio of 51.3%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Pfizer, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.